City page
Photo: Alessandro Ambrosetti · CC BY 2.0Vilnius biotech and pharma directory
Vilnius is the main Lithuanian city represented in this directory for biologics development, molecular tools, genome-editing research, diagnostics, and life-science infrastructure. The records include Northway Biotech, Thermo Fisher’s Vilnius operation, Atrandi Biosciences, CasZyme, and other organisations with documented local sites. Vilnius University provides open-access research services and laboratory infrastructure for external partners. BIO CITY is a Northway Group development with published plans for further facilities; confirm its current delivery status directly with the operator before treating a planned capability as available.
Where does this city read strongest?
Tools (3), Research (3), and CDMO (2). Most visible records: Cureline Baltic, Froceth JSC, and Gensinta UAB.
Which standards and public evidence are already visible?
GMP (5), GLP (3), ISO-13485 (2), and FDA-Inspected (1). Latest review: 24 April 2026. Review cycle: April 2026.
Why does this city matter?
This page brings visible companies and infrastructure records into one practical view of Vilnius.
Related market brief
What the BIO CITY biotechnology city in Vilnius is, how Northway Biotech operates as the 2026 anchor tenant, which capabilities are live at BIO CITY Vilnius today, and how the multi-phase biotech city build-out is progressing - with sources.
Open related briefLocal sources
Primary sources for the local ecosystem
These links let you verify this page’s local context with the primary institution.
Vilnius University research partnerships
Vilnius University’s information on open-access R&D services, laboratory infrastructure, and research-commercialisation partnerships.
Open sourceVilnius University Life Sciences Center
An example of the Life Sciences Center’s research in bioinformatics, including genome editing and CRISPR-related work.
Open sourceBIO CITY project
The operator’s current overview of BIO CITY and its announced facilities and timeline. Treat planned facilities as plans until the operator confirms operations.
Open sourceBy category
Vilnius by category
Jump into a category page filtered to this country only.
Full list
Vilnius biotech and pharma directory
21 city records currently match the active filter.
Current review cycle
Cureline Baltic
VilniusLithuaniaCRO
Vilnius translational and precision-medicine CRO offering human biospecimen procurement, preclinical study design, custom animal models, and bioanalytical laboratory services for Northeastern Europe.
- Lead
- Olga PotapovaFounder and Chief Executive Officer, Cureline Group
- Scale
- CRO service delivery
Current review cycle
Froceth JSC
VilniusLithuaniaTherapeutics
Vilnius advanced-therapy medicinal product (ATMP) manufacturer producing individualized somatic cell-therapy products from patients' own adipose-derived cells, covering anti-cancer vaccines, mesenchymal stem cell preparations, and T-cell therapies for multiple sclerosis.
- Lead
- Agne VaitkevicieneHead and Co-Founder
- Scale
- Individualized ATMP manufacturing
Current review cycle
Gensinta UAB
VilniusLithuaniaTools
Vilnius synthetic biology startup developing a new-generation DNA synthesis technology based on molecular biology and photonics methods, operating from the Vilnius City Innovation Industrial Park (Northtown).
- Lead
- Benas MacijauskasChief Executive Officer
- Scale
- Synthetic biology tools R&D
Current review cycle
Stem Cell Research Center (SCRC)
VilniusLithuaniaResearch
Vilnius Stem Cell Research Center managing the Lithuanian Stem Cell and Regenerative Medicine Cluster, with a disclosed 27 million EUR investment plan at Northtown and a 3D bioprinting research axis under the Northway group.
- Lead
- Vladas Algirdas BumelisFounder and Chairman of the Board, Northway group
- Scale
- Research center and cluster operations
Current review cycle
Vital3D Technologies
VilniusLithuaniaMedical Device
Vilnius 3D bioprinting company developing mesoscale bioprinting systems, vascularized tissue models, and personalized-medicine tools for regenerative and biomedical applications.
- Lead
- Vydmantas ŠakalysDirector
- Scale
- Bioprinting technology and tissue-model development platform
Current review cycle
Saidė Genomics
VilniusLithuaniaGenomics
Vilnius molecular-diagnostics and genomics laboratory delivering NIPT, pharmacogenomics, cancer testing, sequencing services, and personalized research workflows from Lithuania.
- Lead
- Arūnas LeipusDirector
- Scale
- Clinical genomics and sequencing platform
Current review cycle
LT Biotech
VilniusLithuaniaTools
Vilnius diagnostics and bioprocess supplier producing in-vitro diagnostic systems, cell-culture media, sera, and purification materials for research and industrial workflows.
- Lead
- Pavel KarabliovChief Executive Officer
- Scale
- Bioprocess and diagnostic-supply platform for research and industrial users
Current review cycle
Profarma
VilniusLithuaniaCRO
Vilnius pharmaceutical-development and testing platform combining formulation development, analytical services, quality control, and market-access support for complex European programs.
- Lead
- Edita Griniute-MistinieneFounder and Chief Executive Officer
- Scale
- Pharmaceutical development and quality-control platform
Current review cycle
Biomatter
VilniusLithuaniaDrug discovery
Vilnius computational-biology company building generative protein-design tools for enzyme engineering and biological product discovery.
- Lead
- Laurynas KarpusChief Executive Officer and Co-Founder
- Scale
- AI-enabled protein-discovery platform
Current review cycle
Center for Physical Sciences and Technology
VilniusLithuaniaResearch
Vilnius national research institute spanning materials science, photonics, chemistry, and applied life-science instrumentation.
- Lead
- Assoc. Prof. Dr. Rimantas RamanauskasGeneral Director
- Scale
- Large interdisciplinary research institute
Current review cycle
Sunrise Tech Park
VilniusLithuaniaCluster
Vilnius innovation-campus operator connecting Saulėtekis research institutions, spinouts, prototyping support, and commercialization services.
- Lead
- Laima BalčiūnėCEO
- Scale
- Saulėtekis innovation campus operator
Current review cycle
Vilnius University Life Sciences Center
VilniusLithuaniaResearch
Vilnius University flagship life-science campus integrating biochemistry, molecular biology, biotechnology, and training infrastructure.
- Lead
- Assoc. Prof. Dr. Eugenijus ButkusHead of Center
- Scale
- University life-science flagship campus
Current review cycle
State Medicines Control Agency Lithuania
VilniusLithuaniaRegulatory anchor
Vilnius medicines-control authority overseeing national approvals, GMP supervision, pharmacovigilance, and regulated market surveillance.
- Lead
- Dovilė MarcinkėDirector
- Scale
- National medicines-control authority
Current review cycle
Thermo Fisher Supply Vilnius
VilniusLithuaniaInfrastructure anchor
Vilnius supply node for Thermo Fisher's cell-culture and CTS input chain supporting Baltic biologics and advanced-therapy workflows.
- Lead
- Verification pendingVilnius site lead - under review
- Scale
- Global life-science supply node
Current review cycle
World Courier Baltics
VilniusLithuaniaInfrastructure anchor
Vilnius vault node securing GDP and ISO-compliant pharmaceutical storage and specialist transport across the Baltic intake layer.
- Lead
- Laurent BendavidPresident, World Courier
- Scale
- Baltic specialty logistics hub
Current review cycle
Sanobiotec
VilniusLithuaniaManufacturing
Vilnius biotech ingredients and white-label manufacturing platform operating with an ISO-backed quality system and a cannabinoid-processing focus.
- Lead
- Marijus JarockisChief Executive Officer
- Scale
- Regional manufacturing and export platform
Current review cycle
Biotecha
VilniusLithuaniaTools
Vilnius process-equipment and laboratory-infrastructure supplier supporting Lithuanian biotech, pharma, and research facilities with controlled-environment and bioprocess systems.
- Lead
- Gediminas CekanauskasChief Executive Officer
- Scale
- Regional infrastructure supply
Current review cycle
Biotechpharma (Northway)
VilniusLithuaniaCDMO
Vilnius CDMO campus retained in the registry as the historical Biotechpharma operating base within Northway's current biologics manufacturing network.
- Lead
- Vladas Algirdas BumelisCEO, Executive Chairman of the Board and Advisory Board
- Scale
- Commercial CDMO
Current review cycle
CasZyme
VilniusLithuaniaGenomics
Vilnius CRISPR enzyme-discovery and genome-editing company building programmable nuclease platforms, custom research programs, and translational partnerships from its Lithuanian R&D base.
- Lead
- Dr. Giedrius GasiūnasChief Executive Officer and Co-Founder
- Scale
- Molecular
Current review cycle
Atrandi Biosciences
VilniusLithuaniaDiagnostics
Vilnius microfluidics company building single-cell analysis instruments, consumables, and workflow systems around its SPC and droplet technology platforms.
- Lead
- Juozas NainysChief Executive Officer and Co-Founder
- Scale
- Micro-scale
Current review cycle
Northway Biotech
VilniusLithuaniaCDMO
Vilnius biologics CDMO anchor combining mammalian and microbial process development, GMP manufacturing, and BIO CITY expansion capacity inside Lithuania's main biopharma cluster.
- Lead
- Vladas Algirdas BumelisCEO and Chairman of the Board
- Scale
- Commercial CDMO
FAQ
Frequently asked questions
- How many biotech companies are in Vilnius?
- The exact number of visible Vilnius records appears in the page header and updates with each directory refresh. This directory count describes the records that meet Memel Biotech’s current publication standard; it is not a claim to represent every life-science organisation in the city.
- What is the biggest biotech company in Vilnius?
- Rather than assign a single “biggest” company, use the profile evidence for the type of partner you need. Northway Biotech is listed for biologics CDMO services; Thermo Fisher’s Vilnius operation for molecular tools; Atrandi Biosciences and CasZyme for genomics-related work. Confirm the relevant programme, facility, and quality status from the sources attached to each profile.
- What is BIO CITY Vilnius?
- BIO CITY is a Northway Group development project in Vilnius. Its website describes announced facilities for gene therapy, R&D and virology, smart services, stem-cell research, and large-scale production. Timelines and operating status can change, so use the operator’s current information and the related technical brief as starting points, then confirm availability directly before relying on a planned facility.
- What sectors are strongest in Vilnius biotech?
- The current Vilnius records span biologics development, molecular tools, genomics-related technologies, diagnostics, and university research infrastructure. Capability, certification, and commercial availability vary by organisation; use the record-level evidence rather than a city-wide assumption.
Related briefs
Briefs that mention Vilnius
Baltic CRO & Clinical Trial Landscape 2026: Lithuania, Latvia, Estonia
A practical map of the Baltic clinical research organisation landscape - Biomapas, Cureline Baltic, Inpharmatis, Asper Biogene, BioCC - and why Lithuania, Latvia, and Estonia are a credible nearshore option for EU-regulated clinical trials in 2026.
Open briefEuropean Viral Vector CDMO Guide 2026: AAV, Adenovirus, Lentivirus
A source-backed guide to publicly stated European viral-vector CDMO capabilities in 2026: AAV, adenovirus, lentivirus, pDNA, and the questions to ask before a manufacturing enquiry.
Open briefBaltic Biotech Landscape 2026: Lithuania, Latvia, Estonia
A practical map of the Baltic biotech and pharma landscape in 2026 - 74 operators across Lithuania, Latvia, and Estonia, organised by city, category, and what each actually does in the European supply chain.
Open briefNext step
Read the city, then widen the view.
Use country and regional pages for wider context, and the company suggestion form for new candidate records.